Zydus Cadila gets EIR from US FDA for Ankleshwar facility
The EIR report stated that the classification of the facility is "No Action Indicated (NAI)", the company added
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Establishment Inspection Report
Dr Reddy’s Lab gets EIR from US FDA for Vizag units
The US FDA gives EIR on closure of inspection of an establishment that is the subject of an USFDA or US FDA-contracted inspection
Lupin gets EIR from USFDA for Aurangabad facility
The facility was inspected by the US Food and Drug Administration (US FDA) between May 6-15, 2019, Lupin said in a BSE filing
Claris announces receipt of EIR from US FDA
The US FDA had conducted audit at Claris’ manufacturing facility near Ahmedabad in May 2015
Sterile injectables company; Claris…
Torrent Pharma gets establishment nod from US FDA
The plant located at Dahej SEZ, in Gujarat, has also received approval from EU Germany
Torrent Pharma said its third…
Orchid Pharma receives EIR from US FDA
The approval was received on successful inspection closure of its Irungattukottai formulations plant in Tamil Nadu
Orchid Pharma…